Immuneed

Russia
Kholbon, Zabaykalskiy (Transbaikal) Kray, Russia, 752 37

Company profile

Immuneed company profile

Immuneed originated in research at Uppsala University. The company is developing a new generation of prostate cancer vaccines, based on activation of the body's own immune system against tumor cells.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0+
Founded
2014-01-01, Year

Headquarters

Postal code
752 37
Country code
RU
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$504,292
Last funding
Seed / $504,292 / 2016-09-13
Last equity funding
Seed / $504,292
Investors
1
Lead investors
1
Founders
3
Articles
1

Founders and investors

Founders

Erika FletcherSara MangsboThomas Tötterman

Lead investors

Almi Invest

Investors

Almi Invest